These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2784969)

  • 1. Serum C1q level does not predict joint erosion in early rheumatoid arthritis.
    Möttönen T; Hannonen P; Rautiainen J; Jokinen I; Oka M; Arvilommi H
    Arthritis Rheum; 1989 Apr; 32(4):511-2. PubMed ID: 2784969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subsets of chronic rheumatoid arthritis and changes in bone marrow].
    Ochi T
    Nihon Seikeigeka Gakkai Zasshi; 1987 May; 61(5):599-614. PubMed ID: 3498778
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis.
    Ochi T; Iwase R; Yonemasu K; Matsukawa M; Yoneda M; Yukioka M; Ono K
    Arthritis Rheum; 1988 Jan; 31(1):37-43. PubMed ID: 3257874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
    Rosano CL; Parhami N; Hechemy KE; Hurwitz C
    Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for serum C1q based on its hydroxyproline content.
    Rosano CL; Braun CB; Hurwitz C
    Clin Chem; 1987 Mar; 33(3):398-400. PubMed ID: 3102124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C1q levels in rheumatoid arthritis.
    Parhami N; Rosano CL; Hurwitz C
    Arthritis Rheum; 1985 Feb; 28(2):240. PubMed ID: 3871619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complement subcomponent C1q in rheumatic diseases].
    Yonemasu K; Sasaki T
    Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 11. C3 and C1q complement deposits in the membranous labyrinth of patients with Ménière's disease.
    Häusler R; Arnold W; Schifferli J
    Adv Otorhinolaryngol; 1988; 42():116-22. PubMed ID: 3063094
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.
    Rosano CL; Braun CB; Hechemy KE; Parhami N; Satoh PS; Hurwitz C
    Complement; 1988; 5(2):57-64. PubMed ID: 3259913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dissociation properties of native C1.
    Ziccardi RJ; Tschopp J
    Biochem Biophys Res Commun; 1982 Jul; 107(2):618-23. PubMed ID: 6289835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
    Kasukawa R
    Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement subcomponent C1q in various strains of mice. Its serum content correlates with that of immunoglobulin G.
    Yonemasu K; Sasaki T; Hashimoto H; Tsukao N
    Int Arch Allergy Appl Immunol; 1988; 86(1):97-101. PubMed ID: 3259550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit interactions in the first component of complement, C1.
    Lakatos S
    Biochem Biophys Res Commun; 1987 Dec; 149(2):378-84. PubMed ID: 2827640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA nephropathy: a clinicopathological study with emphasis on both nephrotic syndrome and complements.
    Ho YS; Chen A; Sheu LF; Tu YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Dec; 40(6):523-36. PubMed ID: 3509718
    [No Abstract]   [Full Text] [Related]  

  • 20. An ELISA technique for the measurement of C1q in cerebrospinal fluid.
    Delamarche C; Berger F; Pouplard A; Emile J
    J Immunol Methods; 1988 Nov; 114(1-2):101-6. PubMed ID: 3141513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.